General MedicationsINJECTIONStandard
AZTREONAM
AZTREONAM
Standard Dose
500MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview AZTREONAM is listed in Drugs@FDA under application 065439 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AZTREONAM Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2021-11-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview AZTREONAM is listed in Drugs@FDA under application 065439 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AZTREONAM Form and strength INJECTABLE;INJECTION - 500MG/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2021-11-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.